August 30, 2021
PA-18-932 - Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice of Change is to note the inclusion of the National Heart, Lung, and Blood Institute (NHLBI) Catalog of Federal Domestic Assistance (CFDA) Number 93.840 to PA-18-932: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional).
Current language:
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.121; 93.242; 93.273; 93.279; 93.307; 93.399; 93.866, 93.837, 93.838, 93.839, 93.849, 93.233
Revised language in bold and italics:
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.121; 93.242; 93.273; 93.279; 93.307; 93.399; 93.866, 93.837, 93.838, 93.839, 93.840, 93.233
All other aspects of this FOA remain unchanged.
Scientific/Research Contact(s)
Lawton S. Cooper, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Email: cooperls@nhlbi.nih.gov
Telephone: 301-435-0419
Nicole Redmond, MD, PhD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Email: Nicole.Redmond@nih.gov
Telephone: 301-435-0379
Peer Review Contact(s)
Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).
Financial/Grants Management Contact(s)
Gayle Jones
National Heart, Lung, and Blood Institute (NHLBI)
Email: jonesgt@nhlbi.nih.gov
Telephone: 301-827-8040